Join RightBio Metrics at SPN 2025: Making Pediatric NG/OG Tube Placement Safer and Easier

Ensuring Accurate NG/OG Tube Placement in Pediatric Care

Accurate NG/OG tube placement isn’t just a clinical priority—it’s a patient safety imperative in pediatric care. That’s why RightBio Metrics is proud to exhibit at the Society of Pediatric Nurses (SPN) 35th Annual Conference, taking place April 30–May 2, 2025, in Anaheim, California. This year’s event brings together hundreds of pediatric nursing professionals—clinical leaders, educators, and frontline nurses—who are driving safer, smarter care for children nationwide. Join us as we showcase how pH-based tube verification can reduce complications, speed up treatment, and cut down on unnecessary X-rays—all while empowering nurses to make faster, evidence-based decisions at the bedside.

Addressing the Challenges of NG/OG Tube Placement

Accurate placement of nasogastric (NG) and orogastric (OG) tubes is critical in pediatric care. Misplacements can lead to serious complications, including aspiration pneumonia and increased hospital stays. Traditional verification methods, such as X-rays, not only expose young patients to radiation but also incur significant costs and delays.

Other outdated methods like auscultation—the “whoosh test”—are still used in hospitals across the country. This approach lacks clinical evidence and has been shown to produce false positives, leaving room for preventable, and sometimes fatal, errors. In contrast, gastric pH testing offers a faster, more reliable way to confirm placement at the bedside—without the delays, radiation, or subjectivity of traditional methods. Already the standard of care in the UK, pH-based verification is gaining momentum in the U.S. because it works.

Introducing the RightSpotpH® Indicator: A Safer, More Cost-Effective Way to Verify Placement

Designed specifically for pediatric and neonatal patients, the RightSpotpH® SmallBore (ENFit-compatible) provides immediate, bedside verification of NG/OG tube placement using gastric pH. Its closed, color-based system eliminates the guesswork of traditional pH strips and significantly reduces reliance on X-rays—saving hospitals $300–$500 per avoided procedure. By minimizing radiation exposure and enabling faster treatment decisions, this FDA-cleared, CLIA-waived device helps facilities reduce complications, streamline workflows, and improve safety outcomes for some of their most vulnerable patients.